Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ADR
-
Number of holders
-
749
-
Total 13F shares, excl. options
-
272,637,353
-
Shares change
-
+29,584,569
-
Total reported value, excl. options
-
$9,670,376,435
-
Value change
-
+$1,018,117,019
-
Put/Call ratio
-
101%
-
Number of buys
-
219
-
Number of sells
-
448
-
Price
-
$35.47
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2017
As of 31 Dec 2017 GLAXOSMITHKLINE PLC - ADR (GSK) had 749 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 272,637,353 shares of stock of the company.
Largest 10 holders included DODGE & COX, ROYAL BANK OF CANADA, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This table shows 751 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.